interleukin-2 gene

BIOLOGICAL3 trials

Sponsors

St. Jude Children's Research Hospital, H. Lee Moffitt Cancer Center and Research Institute, National Institutes of Health Clinical Center (CC)

Conditions

Head and Neck CancerMelanoma (Skin)Neuroblastoma

Phase 1

Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma

CompletedNCT00062036

National Institutes of Health Clinical Center (CC)Melanoma (Skin)

Start: 2003-06-30End: 2008-09-30Target: 33Updated: 2017-07-02

Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma

CompletedNCT00002748

St. Jude Children's Research HospitalNeuroblastoma

Start: 1991-12-31End: 2007-08-31Updated: 2011-10-04

Phase 2

Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

CompletedNCT00006033

H. Lee Moffitt Cancer Center and Research InstituteHead and Neck Cancer

Start: 2000-06-30End: 2004-06-30Updated: 2013-05-30